Phone (HQ)
+82 428612017
Phone (HQ)
Office Address (HQ)
Research Building 2 70 Yuseong-daero 1689 Beon-Gil Yuseong-gu 2F, Daejeon Daejeon, 34047, South Korea
Office Address (HQ)
Get 10 Free Leads on us
Use our Chrome Extension & instantly connect with prospects
Park Surin
According to Datanyze information, these are Park Surin's contact details. Reveal the hidden information below for FREE!
Phone (HQ)
+82 428612017
Phone (HQ)
Office Address (HQ)
Research Building 2 70 Yuseong-daero 1689 Beon-Gil Yuseong-gu 2F, Daejeon Daejeon, 34047, South Korea
Office Address (HQ)
Park Surin works as a Manager, Clinical Development at PharmAbcine, which is a Business Services company with an estimated 106 employees; and founded in 2008., their management level is Manager. Park is currently based in Daejeon, South Korea.
This is all just the tip of the iceberg. Get to know Park better today! ❄️
PharmAbcine
Research Building 2 70 Yuseong-daero 1689 Beon-Gil Yuseong-gu 2F, Daejeon Daejeon, 34047, South Korea
106
$14.2 M
Business Services, Research & Development
Get Full Profile Access
Ice Breakers
Imagine you could know all about PharmAbcine - Park Surin’s company, before you contact them. Warm up a cold prospect with Datanyze icebreakers
Park’s company in the news
PharmAbcine Announces Safety Approval for 4mg Single-dose Cohort in Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration
October 15, 2024
PharmAbcine Announces Safety Approval for 4mg Single-dose Cohort in Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration
October 15, 2024
PharmAbcine Announces Safety Approval for the First Dose Cohort in Phase 1a/b Clinical Trial of PMC-309 in Patients with Advanced or Metastatic Solid Tumors
July 8, 2024
See more
Insights to Break the Ice
In your first interaction
Park’s CEO is Yoo San
Park is located in South Korea
PharmAbcine’s Funding
Last funding
$6M
August 31, 2009
Total raised
$6M
Work Colleague
See Park Surin's coworkers out of PharmAbcine's 106 employees